Search research articles
Contact Us
Filters
Showing results (251-260 of 376) with videos related to
Page
of 38
Sort By:
The British Journal of Dermatology
|
March 31, 2023
Efficacy and safety of baricitinib in combination with topical corticosteroids in paediatric patients with moderate-to-severe atopic dermatitis with an inadequate response to topical corticosteroids: results from a phase III, randomized, double-blind, placebo-controlled study (BREEZE-AD PEDS)
Antonio Torrelo, Barbara Rewerska, Maria Galimberti, et al.
Health and Quality of Life Outcomes
|
October 24, 2021
Psychometric properties of the itch numeric rating scale, skin pain numeric rating scale, and atopic dermatitis sleep scale in adult patients with moderate-to-severe atopic dermatitis
Jonathan I Silverberg, Amy DeLozier, Luna Sun, et al.
Dermatology and Therapy
|
July 2, 2024
Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations
Melinda J Gooderham, Marjolein de Bruin-Weller, Stephan Weidinger, et al.
Journal of Drugs in Dermatology : JDD
|
February 5, 2026
Efficacy and Safety of Clascoterone Cream 1% for Acne Are Independent of Age and Sex
James Libecco, Lawrence F Eichenfield, Adelaide A Hebert, et al.
American Journal of Clinical Dermatology
|
May 15, 2023
Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study
Lawrence F Eichenfield, Richard G Gower, JinHua Xu, et al.
Journal of Pediatrics. Clinical Practice
|
February 14, 2025
Managing Childhood and Adolescent Atopic Dermatitis in Primary Care: A US Expert Group Consensus
Mark Boguniewicz, Moise L Levy, Lawrence F Eichenfield, et al.
Paediatric Drugs
|
January 24, 2024
Infections in Children Aged 6 Months to 5 Years Treated with Dupilumab in a Placebo-Controlled Clinical Trial of Moderate-to-Severe Atopic Dermatitis
Amy S Paller, Elaine C Siegfried, Michael J Cork, et al.
Dermatology and Therapy
|
March 28, 2024
Maintenance of Investigator's Static Global Assessment Response with Once-Daily Crisaborole in Participants with Mild to Moderate Atopic Dermatitis
Lawrence F Eichenfield, Linda F Stein Gold, Charles Lynde, et al.
Journal of the American Academy of Dermatology
|
September 1, 2023
Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel for moderate-to-severe acne: Efficacy and safety results from two randomized phase 3 trials
Linda Stein Gold, Edward Lain, James Q Del Rosso, et al.
Journal of Drugs in Dermatology : JDD
|
June 19, 2020
Treatment of Impetigo in the Pediatric Population: Consensus and Future Directions
Lawrence A Schachner, Antonio Torrelo, Ayman Grada, et al.
Page
of 38
Search research articles
Search
Showing results (251-260 of 376) with videos related to
Sort By:
Page
of 38
The British Journal of Dermatology
|
March 31, 2023
Efficacy and safety of baricitinib in combination with topical corticosteroids in paediatric patients with moderate-to-severe atopic dermatitis with an inadequate response to topical corticosteroids: results from a phase III, randomized, double-blind, placebo-controlled study (BREEZE-AD PEDS)
Antonio Torrelo, Barbara Rewerska, Maria Galimberti, et al.
Health and Quality of Life Outcomes
|
October 24, 2021
Psychometric properties of the itch numeric rating scale, skin pain numeric rating scale, and atopic dermatitis sleep scale in adult patients with moderate-to-severe atopic dermatitis
Jonathan I Silverberg, Amy DeLozier, Luna Sun, et al.
Dermatology and Therapy
|
July 2, 2024
Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations
Melinda J Gooderham, Marjolein de Bruin-Weller, Stephan Weidinger, et al.
Journal of Drugs in Dermatology : JDD
|
February 5, 2026
Efficacy and Safety of Clascoterone Cream 1% for Acne Are Independent of Age and Sex
James Libecco, Lawrence F Eichenfield, Adelaide A Hebert, et al.
American Journal of Clinical Dermatology
|
May 15, 2023
Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study
Lawrence F Eichenfield, Richard G Gower, JinHua Xu, et al.
Journal of Pediatrics. Clinical Practice
|
February 14, 2025
Managing Childhood and Adolescent Atopic Dermatitis in Primary Care: A US Expert Group Consensus
Mark Boguniewicz, Moise L Levy, Lawrence F Eichenfield, et al.
Paediatric Drugs
|
January 24, 2024
Infections in Children Aged 6 Months to 5 Years Treated with Dupilumab in a Placebo-Controlled Clinical Trial of Moderate-to-Severe Atopic Dermatitis
Amy S Paller, Elaine C Siegfried, Michael J Cork, et al.
Dermatology and Therapy
|
March 28, 2024
Maintenance of Investigator's Static Global Assessment Response with Once-Daily Crisaborole in Participants with Mild to Moderate Atopic Dermatitis
Lawrence F Eichenfield, Linda F Stein Gold, Charles Lynde, et al.
Journal of the American Academy of Dermatology
|
September 1, 2023
Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel for moderate-to-severe acne: Efficacy and safety results from two randomized phase 3 trials
Linda Stein Gold, Edward Lain, James Q Del Rosso, et al.
Journal of Drugs in Dermatology : JDD
|
June 19, 2020
Treatment of Impetigo in the Pediatric Population: Consensus and Future Directions
Lawrence A Schachner, Antonio Torrelo, Ayman Grada, et al.
Page
of 38